Compugen Ltd. (CGEN) Great idea if it works!! But the risk profile of this stock has increased to virtually all or none. The company clearly guided towards many stock moving catalysts in the first half of this year and once again we virtually nothing, but get poor execution and a dilutive event. Compugen shares surge 12% premarket after FDA lifts clinical hold on cancer treatment. The FDA said the company may now start a clinical trial of the antibody, which targets PVRIG in patients with advanced solid tumors. PVRIG is a monoclonal antibody, or one that has the ability to bind with a given target, that Compugen has developed. 1 Wall Street analysts have issued 1 year price objectives for Compugen's shares. Their predictions range from $ to $ On average, they anticipate Compugen's stock price to reach $ in the next year. This suggests a possible upside of % from the stock's current price. View Analyst Price Targets for Compugen.
Stock Market Tips, time: 5:52Tags: Du dudu e edu dublado completo, Dhudial party nohay s, Super smash bros crusade v0.8.4 demo, St micro accelerometer treiber, Dc universe online update time, Caca handika new palapa full, il meglio deve ancora venire video er, changeling robin jenkins themes, bouken-ou beet darkness century music, senam angguk kulon progo dalam